Pegamax Paste 32.4g

Pegamax Oral Paste 32.4g is a broad-spectrum equine dewormer for horses, combining abamectin and praziquantel to provide control of a wide range of internal and external parasite stages.

Pegamax is supplied as a convenient oral paste syringe. One full 32.4g syringe treats one horse weighing 600kg, while each 5.4g mass marking provides sufficient paste for 100kg body mass.

Pegamax controls a comprehensive range of equine parasites, including tapeworms, large and small strongyles, pinworms, ascarids, hairworms, stomach worms, neck threadworms, bots and selected parasite-associated skin lesions and microfilariae.

Active Ingredients

• Abamectin: 3.7mg
• Praziquantel: 46.2mg
• Product size: 32.4g

Key Features & Benefits

• Broad-spectrum horse dewormer
• Oral paste for convenient administration
• Contains abamectin + praziquantel
• Controls tapeworms
• Controls large and small strongyles
• Includes arterial larval stages of Strongylus vulgaris
• Controls pinworms
• Controls ascarids
• Controls hairworms
• Controls large-mouthed stomach worms
• Controls neck threadworms
• Controls bots
• Controls skin lesions caused by Habronema and Draschia spp., according to the supplied product information
• Controls microfilariae of Onchocerca spp., according to the supplied product information
• One 32.4g syringe treats a 600kg horse

Ideal For

• Horses requiring broad-spectrum parasite control
• Horses requiring tapeworm and strongyle control
• Horses requiring control of bots and other listed parasites
• Equine parasite-control programmes where abamectin and praziquantel are appropriate

Directions / Dosage

Administer orally.

The contents of one 32.4g syringe are sufficient to treat one horse weighing 600kg.

Each mass marking on the syringe delivers 5.4g of paste, sufficient to treat 100kg body mass.

Dosage Guide

Do not exceed the recommended dose.

Accurately estimate or weigh the horse's body mass where possible and use the syringe markings to administer the appropriate amount.

Parasites Controlled

Pegamax controls the following parasites according to the supplied product information:

• Tapeworms
• Large strongyles
• Small strongyles
• Arterial larval stages of Strongylus vulgaris
• Pinworms
• Ascarids
• Hairworms
• Large-mouthed stomach worms
• Neck threadworms
• Bots
• Skin lesions caused by Habronema and Draschia spp.
• Microfilariae of Onchocerca spp.

FAQs

What is Pegamax Paste used for?
Pegamax is a broad-spectrum dewormer for horses used to control a wide range of equine parasites, including tapeworms, strongyles, pinworms, ascarids, bots and other parasites listed on the product information.

What are the active ingredients in Pegamax?
Pegamax contains abamectin 3.7mg and praziquantel 46.2mg.

How much Pegamax does a 600kg horse need?
One complete 32.4g syringe is sufficient to treat a horse weighing 600kg.

How much Pegamax is needed for a 100kg horse?
Each syringe marking delivers 5.4g, sufficient for 100kg body mass.

Can I give more than the recommended dose?
No. Do not exceed the recommended dose.

How is Pegamax administered?
Pegamax is administered orally using the supplied syringe.

Does Pegamax treat tapeworms?
Yes. Pegamax contains praziquantel and the supplied product information lists tapeworms among the parasites it controls.

Does Pegamax control strongyles?
Yes. It controls large and small strongyles, including the arterial larval stages of Strongylus vulgaris, according to the supplied information.

Product Information

• Brand: Pegamax
• Product: Pegamax Oral Paste
• Size: 32.4g
• Animal: Horses
• Administration: Oral
• Active ingredients: Abamectin 3.7mg + Praziquantel 46.2mg
• Full syringe: 32.4g
• Full syringe coverage: 600kg body mass
• Syringe marking: 5.4g per 100kg body mass
• Maximum: Do not exceed recommended dose

Important: This is a veterinary deworming product. Use only according to the current product label/package insert. The information supplied does not include minimum age, pregnancy/lactation precautions, treatment interval, resistance-management guidance or withdrawal periods, so these should be added from the current South African label rather than inferred.